Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults [Phase 3]

View source ↗

Summary

Pfizer completed a Phase 3 randomized, double-dummy trial comparing azithromycin sustained-release with a 3-day azithromycin regimen for pharyngitis and tonsill…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pharyngitis
• Tonsillitis

Drugs mentioned

• Azithromycin (3-Day Regimen) (azithromycin)
• Azithromycin Sustained Release (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Pharyngitis, Tonsillitis | Phase 3 | Status: COMPLETED